In malignant mesothelioma (MPM), chemotherapy-mediated suppression of VEGF expression decreased numbers of intratumoral MDSCs and inhibited tumor vessel formation, which significantly enhanced the antitumor effects of anti-PD-1 antibody (117). The gene discussed is VEGFA; the disease is neoplasm.